This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Adenocarcinoma and papilloma adenocarcinoma of rectum (controls excluding all cancers)
C3_RECTUM_ADENO_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C20.92&
Cancer registry: Topography ICD-O-3
C19|C20
Cancer registry: Morphology ICD-O-3
8140
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
2333
C3_RECTUM_ADENO_EXALLC
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma and papilloma adenocarcinoma of rectum (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Adenocarcinoma and papilloma adenocarcinoma of rectum
- Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum
- Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum (controls excluding all cancers)
- Colorectal adenocarcinoma
- Colorectal adenocarcinoma (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2333 | 836 | 1497 |
| Unadjusted prevalence (%) | 0.62 | 0.40 | 0.90 |
| Mean age at first event (years) | 66.78 | 65.05 | 67.75 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_RECTUM_ADENO_EXALLC – Adenocarcinoma and papilloma adenocarcinoma of rectum (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Adenocarcinoma and papilloma adenocarcinoma of rectum (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.